Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Aug 28, 2026 · Filed Sep 1, 2026

On Aug 28, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at an average US$35.77 for US$7.15M under a trading plan, leaving 1,599,154 shares. Filed Sep 1, 2026 (Form 4).

Sold: 200,000 shares
Price: US$35.77 average (US$35.63 to US$36.44)
Value: US$7.15M
Holding after: 1,599,154 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Aug 28, 2026	Common Shares	Option exercise	200,000	US$3.85	1,799,154	Direct
Aug 28, 2026	Common Shares	Sale	166,182	US$35.63	1,632,972	Direct
Aug 28, 2026	Common Shares	Sale	33,818	US$36.44	1,599,154	Direct

Source

View original at SEC

Related